Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2454026 | 0.70 | — | — | |
| SCHEMBL4821047 | 0.70 | — | — | |
| SCHEMBL11217345 | 0.69 | — | — | |
| SCHEMBL11217347 | 0.69 | — | — | |
| SCHEMBL4822827 | 0.69 | — | — | |
| SCHEMBL83558 | 0.67 | — | — | |
| SCHEMBL28199855 | 0.67 | — | — | |
| SCHEMBL11653310 | 0.67 | ALDH1A1 (0.52) | — | |
| SCHEMBL11653315 | 0.67 | ALDH1A1 (0.52) | — | |
| SCHEMBL27739058 | 0.67 | BTN3A1 (0.37) | BTN3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9783559-B2 | β-Ketophosphonic acids and dental materials based thereon | IVOCLAR VIVADENT AG (LI) | 2017-10-10 | — | — | US | disclosed |
| US-20160145277-A1 | B-Ketophosphonic Acids And Dental Materials Based Thereon | IVOCLAR VIVADENT AG (LI) | 2016-05-26 | — | — | US | disclosed |
| CN-105283460-A | [Beta]-ketophosphonic acids and dental materials based thereon | IVOCLAR VIVADENT AG | 2016-01-27 | — | — | CN | disclosed |
| US-6902608-B2 | Dental material containing phosphonic acids | ERNST MUHLBAUER GMBH & CO., KG (DE) | 2005-06-07 | — | — | US | disclosed |
| US-20030167968-A1 | Dental material containing phosphonic acids | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2003-09-11 | — | — | US | disclosed |
| EP-1296634-A1 | DENTAL MATERIAL CONTAINING PHOSPHONIC ACIDS | Ernst Mühlbauer GmbH & Co.KG (DE) | 2003-04-02 | — | — | EP | disclosed |
| WO-2002002057-A1 | DENTAL MATERIAL CONTAINING PHOSPHONIC ACIDS | ERNST MÜHLBAUER GMBH & CO. KG (DE) | 2002-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030167968-A1 | Dental material containing phosphonic acids | PHOSPHO1, EPN1, PTK2 | BTN3A1 1740/4885 |
| US-20160145277-A1 | B-Ketophosphonic Acids And Dental Materials Based Thereon | CYP2B6, GRM6, VKORC1 | BTN3A1 1861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.